Last update Jan. 12, 2022
Very Low Risk
Second generation anti-histaminic drug with low sedative effect. It is metabolized to desloratadine. Oral administration once a day.
Excreted in non-significant amount into breast milk (Hilbert 1988). No side effects were observed in breastfed infants of treated mothers. (Merlob 2002)
Various medical societies and expert consensus consider the use of this medication safe during breastfeeding. (Hale, Briggs 2015, Schaefer 2015, Butler 2014, Amir 2011, So 2010, Leachman 2006, National Asthma Ed. 2004, Nice 2004, Solhaug 2004, Mitchell 1999, Ghaeli 1993)
The British Society of Immunology and Allergy rates it compatible with breastfeeding. (Powell 2007)
American Academy of Pediatrics: medication usually compatible with breastfeeding. (AAP 2001)
We do not have alternatives for R06AX13 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.